BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 8164812)

  • 1. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
    Welsh KA; Butters N; Mohs RC; Beekly D; Edland S; Fillenbaum G; Heyman A
    Neurology; 1994 Apr; 44(4):609-14. PubMed ID: 8164812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders.
    Liu KP; Kuo MC; Tang KC; Chau AW; Ho IH; Kwok MP; Chan WC; Choi RH; Lam NC; Chu MM; Chu LW
    Int Psychogeriatr; 2011 Dec; 23(10):1575-81. PubMed ID: 21729408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.
    Welsh K; Butters N; Hughes J; Mohs R; Heyman A
    Arch Neurol; 1991 Mar; 48(3):278-81. PubMed ID: 2001185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.
    Beeri MS; Schmeidler J; Sano M; Wang J; Lally R; Grossman H; Silverman JM
    Neurology; 2006 Sep; 67(6):1006-10. PubMed ID: 17000969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations.
    Collie A; Shafiq-Antonacci R; Maruff P; Tyler P; Currie J
    Aust N Z J Psychiatry; 1999 Aug; 33(4):568-75. PubMed ID: 10483853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Morris JC; Heyman A; Mohs RC; Hughes JP; van Belle G; Fillenbaum G; Mellits ED; Clark C
    Neurology; 1989 Sep; 39(9):1159-65. PubMed ID: 2771064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).
    Mistridis P; Egli SC; Iverson GL; Berres M; Willmes K; Welsh-Bohmer KA; Monsch AU
    Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):407-17. PubMed ID: 25555899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-, sex-, and education-specific norms for an extended CERAD Neuropsychological Assessment Battery-Results from the population-based LIFE-Adult-Study.
    Luck T; Pabst A; Rodriguez FS; Schroeter ML; Witte V; Hinz A; Mehnert A; Engel C; Loeffler M; Thiery J; Villringer A; Riedel-Heller SG
    Neuropsychology; 2018 May; 32(4):461-475. PubMed ID: 29517259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
    Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.
    Berres M; Monsch AU; Bernasconi F; Thalmann B; Stähelin HB
    Stud Health Technol Inform; 2000; 77():195-9. PubMed ID: 11187541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    Fillenbaum GG; Mohs R
    J Alzheimers Dis; 2023; 93(1):1-27. PubMed ID: 36938738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.
    Welsh KA; Butters N; Hughes JP; Mohs RC; Heyman A
    Arch Neurol; 1992 May; 49(5):448-52. PubMed ID: 1580805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample.
    Guruje O; Unverzargt FW; Osuntokun BO; Hendrie HC; Baiyewu O; Ogunniyi A; Hali KS
    West Afr J Med; 1995; 14(1):29-33. PubMed ID: 7626529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population.
    Han JY; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Choi HJ; Kim SG; Park SY; Kim JW; Youn JC; Jhoo JH; Lee JH; Kim KW; Woo JI; Lee DY
    Int Psychogeriatr; 2014 Nov; 26(11):1897-904. PubMed ID: 25075438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.